DNTH

Dianthus Therapeutics, Inc. /DE/

Pharmaceutical Preparations · SIC 2834CIK 1690585Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

7 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

3.2%

—

$34.5M

$1.10B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

1.1%

+10.3%

$109.7M

$9.59B13F book · 2026-06-30

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.42%

—

$83.1M

$19.96B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

0.21%

NEW

$11.2M

$5.25B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.03%

+15.6%

$18.0M

$71.32B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.03%

+52.7%

$5.4M

$21.33B13F book · 2026-06-30

Polen Capital Management

PolenPosition history →

0.01%

+126.6%

$0.9M

$11.61B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.